ECSP992843A - PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTION - Google Patents
PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTIONInfo
- Publication number
- ECSP992843A ECSP992843A ECSP992843A ECSP992843A EC SP992843 A ECSP992843 A EC SP992843A EC SP992843 A ECSP992843 A EC SP992843A EC SP992843 A ECSP992843 A EC SP992843A
- Authority
- EC
- Ecuador
- Prior art keywords
- sexual dysfunction
- apomorphine
- procedure
- female sexual
- clitoris
- Prior art date
Links
- 206010057671 Female sexual dysfunction Diseases 0.000 title 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 abstract 3
- 229960004046 apomorphine Drugs 0.000 abstract 3
- 230000017531 blood circulation Effects 0.000 abstract 2
- 210000003029 clitoris Anatomy 0.000 abstract 2
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007383 nerve stimulation Effects 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 210000001215 vagina Anatomy 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se puede aminorar la disfunción sexual de las mujeres, sin efectos colaterales indeseables, por medio de la administarción sublingual de formas dosificadas de apomorfina. La administarción de apomorfina incrementa el flujo sanguineo intracavernoso en el clitoris por estimulación nerviosa y el flujo sanguineo en las paredes vaginales lo cual mejora la erección del clitoris y el llenado vascular de la vagina en una mujer. Se mantienen de preferencia una concentración de plasma de apomorfina en un nivel no mayor a los 5,5 manogramos por milímetro.Sexual dysfunction in women can be lessened, without undesirable side effects, by sublingual administration of apomorphine dosage forms. The administration of apomorphine increases intracavernous blood flow in the clitoris by nerve stimulation and blood flow in the vaginal walls, which improves the erection of the clitoris and the vascular filling of the vagina in a woman. Preferably, a plasma concentration of apomorphine is maintained at a level not greater than 5.5 manograms per millimeter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992843 ECSP992843A (en) | 1999-01-29 | 1999-01-29 | PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992843 ECSP992843A (en) | 1999-01-29 | 1999-01-29 | PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992843A true ECSP992843A (en) | 1999-06-01 |
Family
ID=42043833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992843 ECSP992843A (en) | 1999-01-29 | 1999-01-29 | PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992843A (en) |
-
1999
- 1999-01-29 EC ECSP992843 patent/ECSP992843A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR5959A (en) | TREATMENT FOR FEMALE SEXUAL DYSFUNCTION | |
| BRPI0412493A (en) | Hormonal treatment methods using contraceptive regimens with continuous estrogen administration | |
| PE20010925A1 (en) | NEUROPEPTIDE INHIBITING COMPOUNDS AND USEFUL FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION | |
| NO20014519D0 (en) | Apomorphine and Sildenafil Preparation | |
| NZ510359A (en) | Amelioration of apomorphine adverse effects for sexual dysfunction in males and females | |
| EP1652520B1 (en) | Formulations useful in the treatment of male and female impotence | |
| NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
| ECSP992843A (en) | PROCEDURE TO REDUCE FEMALE SEXUAL DYSFUNCTION | |
| AR019694A1 (en) | METHOD FOR THE TREATMENT OR REDUCTION OF FEMALE SEXUAL DYSFUNCTION. | |
| CN2721086Y (en) | A male functional assisting device | |
| CN104490512A (en) | Condom used for treating sexual apathy and psychosexual disorder | |
| TH65931A3 (en) | Medicines for women with sexual dysfunction and their use | |
| CN204446253U (en) | The condom of a kind of therapeutic indifference and psychosexual disorder | |
| RU2275895C2 (en) | Method for treating chronic cervicitis | |
| AR026506A1 (en) | A MEDICATION FOR THE PREVENTION AND TREATMENT OF SEXUAL DYSFUNCTION | |
| JPS6447717A (en) | Infectious disease preventing drug | |
| RU2544163C1 (en) | Therapeutic agent in form of gel for treating herpetic infection manifestations in patients with burns and cold injuries | |
| CN210904674U (en) | Anti-inflammatory device | |
| CN201085724Y (en) | Time-delay massage sleeve | |
| CN2166794Y (en) | Condom for preventing premature ejaculation | |
| RU2351358C2 (en) | Application of lh for treatment of libido absence and achievement of orgasm | |
| CN100413523C (en) | Anal fistula treating Chinese medicine | |
| CN210844919U (en) | Adult autonomous defecation stimulator | |
| CN2915090Y (en) | Male genitals nerve massaging rubber ring | |
| CN2198890Y (en) | Device for promoting penis erection |